← Leaderboards
Jeffrey H Thomas
Tosk, Inc.
$999,936
Attributed
$1,999,872
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2017–18$2M$1.5M$1M$500K$0
'17
'18
Funding mix
By agency
NIH$1,999,872 · 1
By mechanism
R44$1,999,872 · 1
Top collaborators
- William A. Garland2 shared
Others in their field
Other Emerging Leaders on “Adme Study”
- Timothy M Willson · University Of Cape Town$12,760,250
- Anna Upton · Global Alliance For Tb Drug Development$10,496,979
- Christian Arthur Heidbreder · Indivior, Inc.$8,483,680
- John Damon Chodera · Sloan-Kettering Inst Can Research$8,477,219
- James Jeffrey Sahn · 4e Therapeutics Inc.$7,126,294
- Deborah Bunin · Sri International$6,795,541
Research focus
Adme StudyActive SitesBackBaseBypassCancer PatientCancer TherapyCell Culture TechniquesCell ProliferationCell SurfaceCell SurvivalCetuximabColorectalColorectal CancerCompanionsDesignDockingDrosophila GenusDrosophila MelanogasterDrug KineticsDrug ReceptorsEgf GeneEpidermal Growth Factor ReceptorErbitux